pentoxifylline has been researched along with Arteriosclerosis in 37 studies
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline was stopped and intravenous heparin therapy was initiated." | 6.67 | Pain relief and clinical improvement temporally related to the use of pentoxifylline in a patient with documented cholesterol emboli--a case report. ( Carr, ME; Sanders, K; Todd, WM, 1994) |
| "To evaluate the use of pentoxifylline to treat impotence in men with mild to moderate penile vascular insufficiency." | 5.07 | Treatment of vasculogenic sexual dysfunction with pentoxifylline. ( Korenman, SG; Viosca, SP, 1993) |
| "Ten patients with chronic occlusive arteriosclerosis received single oral doses of 100, 200, 400, 800, and 1200 mg pentoxifylline in a single-blind, placebo-controlled study." | 5.06 | Dose-response effects of pentoxifylline on erythrocyte filterability: clinical and animal model studies. ( Ambrus, JL; Anain, JM; Anain, PM; Anain, SM; Brobst, JA; Cobert, BL; Mitchell, P; Savitsky, JP; Stadler, S, 1990) |
| "Patients who have had a recent transient ischemic attack (TIA) are at high risk for subsequent stroke." | 3.77 | Epidemiology of and stroke-preventive strategies for atherothromboembolic brain infarction in the elderly. ( Adams, HP; Gordon, DL, 1991) |
| "A study was carried out in 127 patients (94 males and 33 females) presenting with arteriosclerosis (88 patients) or diabetic vasculopathy (39 patients) in different stages of severity (Fontaine) to assess the effectiveness and tolerance of treatment with high doses of pentoxifylline." | 3.67 | Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses. ( Antignani, PL; Bartolo, M; Pacino, G; Saliceti, F; Todini, AR, 1987) |
| "Pentoxifylline treatment did not affect the plasma levels of the 3 other variables, von Willebrand factor, 6-keto prostaglandin F1 alpha and thromboxane B2." | 2.67 | Platelet activation in diabetic patients with asymptomatic atherosclerosis. ( Imano, E; Kamada, T; Kawamori, R; Kodama, M; Matsushima, H; Nishizawa, H; Watarai, T; Yamasaki, Y, 1994) |
| "Pentoxifylline was stopped and intravenous heparin therapy was initiated." | 2.67 | Pain relief and clinical improvement temporally related to the use of pentoxifylline in a patient with documented cholesterol emboli--a case report. ( Carr, ME; Sanders, K; Todd, WM, 1994) |
| "Pentoxifylline used in the treatment of vascular diseases has also some immunological effects." | 1.30 | [In vitro and clinical effect of pentoxifylline on natural killer cell activity]. ( Balogh, A; Mándi, Y; Nagy, Z; Ocsovszki, I; Sipka, R, 1998) |
| "Pentoxifylline was used in the treatment of 90 patients with atherosclerosis-induced chronic peripheral arterial occlusive disease and diabetic vascular disorders in the lower extremities (clinical Fontaine Stages III and IV) for whom surgical reconstructive treatment was not indicated and who had shown inadequate response to previous therapy." | 1.27 | Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease. ( Seige, K; Sternitzky, R, 1985) |
| "The pentoxifylline-induced increase in RCF was less marked in Group II; only the rigidity parameter was significantly decreased." | 1.26 | Effect of pentoxifylline on red cell flexibility in arterio-sclerotic patients and in patients with heart valve prosthesis. ( Harjola, PT; Johnsson, R; Siltanen, P, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (54.05) | 18.7374 |
| 1990's | 11 (29.73) | 18.2507 |
| 2000's | 6 (16.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhdanova, IV | 1 |
| Tsvirenko, SV | 1 |
| Barats, SS | 1 |
| Smolenskaia, OG | 1 |
| Volkova, RF | 1 |
| Serezhenko, TO | 1 |
| Drozdz, W | 1 |
| Kedryna, T | 1 |
| Ostrowska, B | 1 |
| Wilczek, M | 1 |
| Stachurska, B | 1 |
| Alekhin, DI | 1 |
| Fokin, AN | 1 |
| Galenko-Yaroshevskii, PA | 1 |
| Alukhanyan, OA | 1 |
| Kurganskii, OV | 1 |
| Fedchenko, YY | 1 |
| Stoltz, JF | 1 |
| Perhoniemi, V | 1 |
| Salmenkivi, K | 1 |
| Sundberg, S | 1 |
| Johnsson, R | 2 |
| Gordin, A | 1 |
| Marcel, GA | 1 |
| Weill, D | 1 |
| Catry, E | 1 |
| Thao-Chan, M | 1 |
| George, C | 1 |
| Gueguen, M | 1 |
| Driss, F | 1 |
| Hanss, M | 1 |
| Koutsouris, D | 1 |
| Maughan, RJ | 1 |
| Broom, J | 1 |
| Smith, G | 1 |
| Leiper, JB | 1 |
| Ah-See, AK | 1 |
| Engeset, J | 1 |
| Evan-Wong, A | 1 |
| Davidson, RJ | 1 |
| Harjola, PT | 1 |
| Siltanen, P | 1 |
| Gastpar, H | 2 |
| Shtok, VN | 1 |
| Fedorova, NV | 1 |
| Gadanova, IV | 1 |
| Vogralik, VG | 1 |
| Vogralik, MV | 1 |
| Runov, GP | 1 |
| Runova, AA | 1 |
| Kostrov, AI | 1 |
| Ruberti, U | 1 |
| Morbidelli, A | 1 |
| Kawamori, R | 1 |
| Imano, E | 1 |
| Watarai, T | 1 |
| Nishizawa, H | 1 |
| Matsushima, H | 1 |
| Kodama, M | 1 |
| Yamasaki, Y | 1 |
| Kamada, T | 1 |
| Carr, ME | 1 |
| Sanders, K | 1 |
| Todd, WM | 1 |
| Akopov, SE | 1 |
| Gabrielian, ES | 1 |
| Korenman, SG | 1 |
| Viosca, SP | 1 |
| Nagy, Z | 1 |
| Sipka, R | 1 |
| Ocsovszki, I | 1 |
| Balogh, A | 1 |
| Mándi, Y | 1 |
| Laurat, E | 1 |
| Poirier, B | 1 |
| Tupin, E | 1 |
| Caligiuri, G | 1 |
| Hansson, GK | 1 |
| Bariéty, J | 1 |
| Nicoletti, A | 1 |
| Regensteiner, JG | 1 |
| Hiatt, WR | 1 |
| Belousov, IuB | 1 |
| Savenkov, PM | 1 |
| Sidel'man, AA | 1 |
| Parfenov, AS | 1 |
| Savenkov, MP | 1 |
| Ambrus, JL | 2 |
| Ambrus, CM | 1 |
| Zicot, M | 1 |
| Verhaeghe, R | 1 |
| Verstraete, M | 1 |
| Adams, HP | 1 |
| Gordon, DL | 1 |
| Caimi, G | 1 |
| Serra, A | 1 |
| Francavilla, G | 1 |
| Romano, A | 1 |
| Catania, A | 1 |
| Sarno, A | 1 |
| Anain, JM | 2 |
| Anain, SM | 1 |
| Anain, PM | 1 |
| Stadler, S | 1 |
| Mitchell, P | 1 |
| Brobst, JA | 1 |
| Cobert, BL | 1 |
| Savitsky, JP | 1 |
| De Felice, M | 1 |
| Gallo, P | 1 |
| Masotti, G | 1 |
| Schwartz, RW | 1 |
| Logan, NM | 1 |
| Johnson, PJ | 1 |
| Strodel, WE | 1 |
| Fine, JG | 1 |
| Kazmers, A | 1 |
| Hyde, GL | 1 |
| Tesi, M | 1 |
| Bronchi, GF | 1 |
| Carini, A | 1 |
| Karavassili, M | 1 |
| Manrique, RV | 1 |
| Manrique, V | 1 |
| Jarcusková, D | 1 |
| Uhrík, J | 1 |
| Sidorenko, GI | 1 |
| Tsapaev, VG | 1 |
| Tsapaeva, NL | 1 |
| Atroshchenko, ES | 1 |
| Antignani, PL | 1 |
| Todini, AR | 1 |
| Saliceti, F | 1 |
| Pacino, G | 1 |
| Bartolo, M | 1 |
| Wesołowski, J | 1 |
| Hubl, S | 1 |
| Szubski, J | 1 |
| Weinzieher, E | 1 |
| Rykowski, H | 1 |
| Sternitzky, R | 1 |
| Seige, K | 1 |
6 reviews available for pentoxifylline and Arteriosclerosis
| Article | Year |
|---|---|
Red blood cell microrheology (clinical and pharmacological applications).
Topics: Animals; Arteriosclerosis; Blood Viscosity; Calcium; Cardiovascular Diseases; Cinnarizine; Elasticit | 1983 |
New aspects of the pathogenesis of atherosclerosis: possible approaches to prevention and treatment.
Topics: Animals; Arteriosclerosis; Humans; Pentoxifylline | 1981 |
Current medical therapies for patients with peripheral arterial disease: a critical review.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Cardiovascular Diseases; Cilostazol; Dia | 2002 |
[is there a treatment for peripheral arterial insufficiency?].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clofibrate; Dipyridamole; Fibrinolytic Agent | 1979 |
Epidemiology of and stroke-preventive strategies for atherothromboembolic brain infarction in the elderly.
Topics: Aged; Anticoagulants; Arteriosclerosis; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Fem | 1991 |
Current therapy of peripheral obstructive arterial disease. The non-surgical approach.
Topics: Anticoagulants; Arteriosclerosis; Clinical Trials as Topic; Double-Blind Method; Exercise; Hemodilut | 1990 |
12 trials available for pentoxifylline and Arteriosclerosis
| Article | Year |
|---|---|
Energostim in therapy of chronic ischemia of the lower limbs.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Coronary Disease; Cytochromes c; Drug Combinations | 2004 |
Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication.
Topics: Aged; Arteriosclerosis; Blood Pressure; Blood Viscosity; Cinnarizine; Clinical Trials as Topic; Doub | 1984 |
Platelet activation in diabetic patients with asymptomatic atherosclerosis.
Topics: Aged; Arteriosclerosis; beta-Thromboglobulin; Blood Pressure; Carotid Arteries; Carotid Artery Disea | 1994 |
Pain relief and clinical improvement temporally related to the use of pentoxifylline in a patient with documented cholesterol emboli--a case report.
Topics: Aged; Arteriosclerosis; Embolism, Cholesterol; Humans; Male; Pain; Pentoxifylline | 1994 |
The relationship between the degradation of prostacyclin in blood and antiplatelet drug effects in patients with atherosclerosis.
Topics: Arteriosclerosis; Dipyridamole; Double-Blind Method; Epoprostenol; Humans; Kinetics; Middle Aged; Ni | 1993 |
Treatment of vasculogenic sexual dysfunction with pentoxifylline.
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Blood Pressure; Brachial Artery; Coitus; Comorb | 1993 |
[Pharmacotherapy of peripheral arteriosclerosis].
Topics: Aged; Arteriosclerosis; Arteriosclerosis Obliterans; Azepines; Clinical Trials as Topic; Drug Evalua | 1978 |
Epidemiology of and stroke-preventive strategies for atherothromboembolic brain infarction in the elderly.
Topics: Aged; Anticoagulants; Arteriosclerosis; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Fem | 1991 |
Dose-response effects of pentoxifylline on erythrocyte filterability: clinical and animal model studies.
Topics: Animals; Arteriosclerosis; Disease Models, Animal; Dose-Response Relationship, Drug; Erythrocyte Def | 1990 |
Current therapy of peripheral obstructive arterial disease. The non-surgical approach.
Topics: Anticoagulants; Arteriosclerosis; Clinical Trials as Topic; Double-Blind Method; Exercise; Hemodilut | 1990 |
Therapy of atherosclerotic arteriopathy of lower limbs. Aspects and results.
Topics: Acute Disease; Arteriosclerosis; Chronic Disease; Clinical Trials as Topic; Glycosaminoglycans; Hepa | 1985 |
[Clinical evaluation of the preparation Trental].
Topics: Adult; Aged; Arteriosclerosis; Clinical Trials as Topic; Female; Humans; Leg; Male; Middle Aged; Pen | 1985 |
21 other studies available for pentoxifylline and Arteriosclerosis
| Article | Year |
|---|---|
[Effect of fluvastain and its combination with aspirin and trental on hemostasis and microcirculation in atherosclerosis].
Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Aspirin; Drug Therapy, Combination; Fatty A | 2002 |
[Erythrocyte concentrations of adenosine triphosphate (ATP) and magnesium, before and after conservative therapy of lower extremities atherosclerosis].
Topics: Adenosine Triphosphate; Adult; Aged; Arteriosclerosis; Erythrocytes; Female; Humans; Ischemia; Lower | 2004 |
[A new method of treatment of chronic ischemia of extremities with the primary lesion of the distal arterial bed (experimental-clinical investigation)].
Topics: Aged; Animals; Anti-Bacterial Agents; Anticoagulants; Arteriosclerosis; Catheterization; Chronic Dis | 2004 |
Red cell deformability as a criterion of surface hemorheological changes: clinical and pharmacological approaches.
Topics: Arteriosclerosis; Calcium; Erythrocytes; Fibrinogen; Glutaral; Hematocrit; Humans; Leukocyte Count; | 1983 |
Whole blood and red cell ATP content in patients with peripheral vascular disease: the effect of cigarette smoking and oxpentifylline.
Topics: Adenosine Triphosphate; Age Factors; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Erythrocyt | 1984 |
Effect of pentoxifylline on red cell flexibility in arterio-sclerotic patients and in patients with heart valve prosthesis.
Topics: Adult; Aortic Valve; Arteriosclerosis; Erythrocyte Membrane; Erythrocytes; Female; Heart Valve Prost | 1981 |
[Clinical study of the cerebrovascular action of pentoxifylline].
Topics: Acute Disease; Adult; Arteriosclerosis; Brain Ischemia; Cerebrovascular Disorders; Chronic Disease; | 1982 |
[Trental treatment of microcirculatory disorders in diabetes mellitus and arteriosclerosis].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Blood Viscosity; Diabetic Angiopathies; Drug Evaluation; | 1982 |
[Role and possible control of the risk factors in atherosclerotic vasculopathies for the evaluation of results of surgical treatment. Preliminary study on the use of pentoxifylline].
Topics: Arteriosclerosis; Erythrocytes; Female; Hematocrit; Humans; Ischemia; Leg; Male; Pentoxifylline; Ult | 1981 |
Atherosclerosis and pentoxifylline. Proceedings of an international symposium. Prague, 10-12 October 1996.
Topics: Animals; Arteriosclerosis; Humans; Pentoxifylline; Phosphodiesterase Inhibitors; Vasodilator Agents | 1997 |
[In vitro and clinical effect of pentoxifylline on natural killer cell activity].
Topics: Adult; Aged; Apoptosis; Arteriosclerosis; Female; Hematologic Agents; Humans; In Vitro Techniques; K | 1998 |
In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice.
Topics: Animals; Apolipoproteins E; Arteriosclerosis; Body Weight; Cell Count; Cell Differentiation; Cells, | 2001 |
Studies on platelet aggregation with pentoxifylline: effect on neoplastic disorders and other new indications.
Topics: Anemia, Sickle Cell; Animals; Arteriosclerosis; Blood Viscosity; Embolism; Haplorhini; Humans; Neopl | 1979 |
Pentoxifylline in arterial disease of the legs.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Clinical Trials as Topic; Fibrinolytic Agents; Humans | 1991 |
Vascular atherosclerotic disease: evaluation of the whole-blood filterability and red cell membrane microrheological pattern after intravenous administration of a single dose of pentoxifylline.
Topics: Aged; Arteriosclerosis; Blood Viscosity; Erythrocyte Deformability; Erythrocyte Membrane; Humans; In | 1990 |
Pentoxifylline increases extremity blood flow in diabetic atherosclerotic patients.
Topics: Arteries; Arteriosclerosis; Diabetes Mellitus; Diabetic Angiopathies; Exercise Test; Female; Humans; | 1989 |
Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Blood Platelets; Cyclic AMP; Drug Resist | 1987 |
[Evaluation of thermal conductivity and skin temperature in the treatment of leg ulcers].
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Diabetic Angiopathies; Female; Humans; Leg; Leg Ul | 1988 |
[Effect of treatment with trental on indicators of peripheral hemodynamics and blood lipid level in patients with arteriosclerosis of the lower extremities].
Topics: Arteriosclerosis; Capillary Permeability; Hemodynamics; Humans; Leg; Lipids; Male; Pentoxifylline; T | 1987 |
Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses.
Topics: Aged; Arteriosclerosis; Blood Pressure; Diabetic Angiopathies; Erythrocyte Deformability; Female; Hu | 1987 |
Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Diabetes Mellitus, Type 1; Diabetes Mell | 1985 |